비뇨기과 레이저 시장 보고서 : 레이저 유형별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global urology laser market size reached USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.2% during 2025-2033. The increasing prevalence of urological disorders, rising expenditure capacities of consumers, and extensive research and development (R&D) activities are some of the key factors driving the market.

Urology lasers are medical devices or components used in the diagnosis and treatment of urological conditions. Holmium, diode, and thulium are some of the commonly used laser systems. They are widely used to treat kidney stones, ureteral cancer, urinary tract obstruction, and bladder and upper urinary tract urothelial tumors. They emit a tiny beam of monochromatic light through various materials, such as semiconductors and crystals, that offer an accurate, precise, and painless surgical treatment. Urology lasers provide numerous benefits in the diagnosis and treatment of urological conditions as they are minimally invasive that help in the efficient treatment of many urological disorders with minimal risks and complications. As a result, urology lasers are extensively used across hospitals, urology clinics, and ambulatory surgical centres.

Urology Laser Market Trends:

The increasing prevalence of urological disorders across the globe is one of the key factors driving the market growth. Urology laser is widely used in various conditions, such as kidney stones, bladder cancer, ureteral cancer, and urinary tract obstruction. In line with this, the rising geriatric population prone to kidney problems, disorders, and conditions are favoring the market growth. Moreover, the widespread product adoption in the treatment of benign prostatic hyperplasia (BPH) condition that involves the enlargement of the prostate gland, which is highly prevalent in males, is acting as another growth-inducing factor. Apart from this, the increasing demand for urology lasers over traditional surgical methods as they are minimally invasive (MI) and lower risks of complications such as bleeding and infection, making them a preferred treatment option for elderly patients with multiple comorbidities, which in turn is propelling the market growth. Additionally, the introduction of green light laser therapy that utilizes a small thin, and flexible fibre that is inserted into the urethra and assists in normal urine flow from the bladder to be restored, and it also eases away your urinary symptoms is providing an impetus to the market growth. Other factors, including rising expenditure capacities of consumers, significant growth in the healthcare industry, extensive research and development (R&D) activities, rapid advancements in urology laser technology, and increasing awareness about the safety characteristics and effectiveness of these urology laser systems, are anticipated to drive the market growth.

Key Market Segmentation:

Laser Type Insights:

• Holmium Laser System
• Diode Laser System
• Thulium Laser System
• Others

Application Insights:

• Benign Prostatic Hyperplasia (BPH)
• Urolithiasis
• Non-Muscle-Invasive Bladder Cancer (NMIBC)
• Others

End User Insights:

• Hospitals
• Urology Clinics
• Ambulatory Surgical Centres
• Others

Regional Insights:

• North America
• United States
• Canada
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
• The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for urology laser. Some of the factors driving the North America urology laser market included rising expenditure capacities of consumers, significant growth in the healthcare industry, and rapid technological advancements.

Competitive Landscape:

• The report has also provided a comprehensive analysis of the competitive landscape in the global urology laser market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Allengers Medical Systems Limited, Asclepion Laser Technologies GmbH, Boston Scientific Corporation Incorporated, Convergent Laser Technologies, Cook Medical LLC (Cook Group Incorporated), Healthtronics Inc., Hyper Photonics s.r.l., Olympus Corporation, OmniGuide Holdings Inc., Quanta System S.p.A. (El. En SpA Group), Richard Wolf GmbH, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

• How has the global urology laser market performed so far, and how will it perform in the coming years?
• What are the drivers, restraints, and opportunities in the global urology laser market?
• What is the impact of each driver, restraint, and opportunity on the global urology laser market?
• What are the key regional markets?
• Which countries represent the most attractive urology laser market?
• What is the breakup of the market based on the laser type?
• Which is the most attractive laser type in the urology laser market?
• What is the breakup of the market based on the application?
• Which is the most attractive application in the urology laser market?
• What is the breakup of the market based on the end user?
• Which is the most attractive end user in the urology laser market?
• What is the competitive structure of the global urology laser market?
• Who are the key players/companies in the global urology laser market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Urology Laser Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Laser Type

• 6.1 Holmium Laser System
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Diode Laser System
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Thulium Laser System
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Application

• 7.1 Benign Prostatic Hyperplasia (BPH)
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Urolithiasis
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Non-Muscle-Invasive Bladder Cancer (NMIBC)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Urology Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centres
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Allengers Medical Systems Limited
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Asclepion Laser Technologies GmbH
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Boston Scientific Corporation Incorporated
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Convergent Laser Technologies
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Cook Medical LLC (Cook Group Incorporated)
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 SWOT Analysis
  • 14.3.6 Healthtronics Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 SWOT Analysis
  • 14.3.7 Hyper Photonics s.r.l.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
  • 14.3.8 Olympus Corporation
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 OmniGuide Holdings Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Quanta System S.p.A. (El. En SpA Group)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Richard Wolf GmbH
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.